Fig. 3From: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in UgandaUncorrected and PCR-corrected Kaplan–Meier survival curves of time to treatment failure among participants enrolled in therapeutic efficacy monitoring, Uganda, 2018–2019. AL artemether-lumefantrine, DP dihydroartemisinin-piperaquinBack to article page